Cynosure Lutronic reports 3x faster treatment cycles for XERF, driving rapid clinic adoption and changing device ROI calculations.
Cynosure Lutronic's XERF radiofrequency platform is seeing accelerated worldwide adoption, with the company reporting that the device now operates 3x faster than prior generations. XERF is a monopolar RF device cleared for skin tightening and collagen remodeling—a core offering in the energy-device market alongside fractional CO2, erbium, and microneedling RF.
The speed advantage is operationally critical. Faster treatment cycles directly improve patient throughput and device ROI. A practice can treat more patients per day, reducing the per-procedure cost allocation and improving break-even patient volume. This is particularly relevant for high-volume aesthetic practices where device utilization drives profitability.
3x faster treatment cycles reshape device ROI and patient throughput economics.
XERF competes with InMode's Morpheus8 RF microneedling and traditional monopolar RF systems. The adoption velocity suggests practices are prioritizing treatment speed and efficiency—a signal that device economics (not just clinical outcomes) are driving purchasing decisions. For owners evaluating RF modalities, the throughput data should factor heavily into your acquisition and leasing analysis.
Source: original report ↗
Free alerts Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo Join the owners who run ahead of the industry. Cancel anytime, one click.
